ZHANGKE LINGYI INVESTMENT
ZHANGKE LINGYI INVESTMENT
Founded:
2015-01-01
Status:
Active
Similar Organizations
Alkemi Venture Partners
Alkemi Venture Partners is a investment Company.
FutureX Capital
FutureX Capital is an investment firm.
Hua Capital
Hua Capital emphases on professional, international and industrial Chain-focusing investment philosophy.
Huiyou Investment
Huiyou Investment is an investment firm.
Inspiration Capital
Inspiration Capital is an investment firm.
Ludus
Ludus finds, invests in, and nurtures the best-in-class gaming startups.
QV Equities
QV Equities offers investment opportunities through a diversified portfolio of ASX entities to achieve long term capital growth and income.
Spring Point Partners
Spring Point Partners is an investment firm.
Suzhou Xiangcheng Financial Holding Group
Suzhou Xiangcheng Financial Holding Group is an investment company.
TS Investment
TS Investment is an investment company.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-06-07 | MySci Biotech | Zhangke Lingyi Investment investment in Seed Round - MySci Biotech | N/A |
| 2023-11-24 | Huanqing Medical | Zhangke Lingyi Investment investment in Series A - Huanqing Medical | N/A |
| 2023-08-07 | Leadopharma | Zhangke Lingyi Investment investment in Series A - Leadopharma | N/A |
| 2023-05-04 | NeuExcell Therapeutics | Zhangke Lingyi Investment investment in Seed Round - NeuExcell Therapeutics | 15 M USD |
| 2023-04-03 | Bioyond Tech | Zhangke Lingyi Investment investment in Series A - Bioyond Tech | 200 M CNY |
| 2022-12-27 | Jingzhu Biology | Zhangke Lingyi Investment investment in Series A - Jingzhu Biology | N/A |
| 2021-03-24 | ImmuneOnco Biopharma | Zhangke Lingyi Investment investment in Series C - ImmuneOnco Biopharma | N/A |
| 2017-09-13 | Ennovabio | Zhangke Lingyi Investment investment in Seed Round - Ennovabio | 10 M USD |
More informations about "Zhangke Lingyi Investment"
Zhangke Lingyi Investment - Crunchbase Investor Profile
Zhangke Lingyi Investment is an investment company. Headquarters Regions Asia-Pacific (APAC); Founded Date 2015; Operating Status Active; Also Known As Shanghai Zhangke …See details»
Zhangke Lingyi Investment - Investments, Portfolio & Company Exits
Jun 7, 2024 Zhangke Lingyi Investment has made 9 investments. Their most recent investment was on Nov 18, 2024 , when Lingtai Biotechnology raised CN¥100M . Zhangke Lingyi …See details»
Zhangke Lingyi - CB Insights
Zhangke Lingyi is based in China. Use the CB Insights Platform to explore Zhangke Lingyi's full profile. Technology Vendors; Recent Research ... Their latest investment was in Leading Tac …See details»
Zhangke Lingyi Qifan Venture Fund: Performance - PitchBook
Zhangke Lingyi Qifan Venture Fund is a 2021 vintage venture capital fund managed by Yongkan Investment. The fund is located in Shanghai and will invest in biomedicine companies in …See details»
Zhangkelingyi - Crunchbase Investor Profile & Investments
Investment Thesis . Overview. Zhangkelingyi invests in seed to late-stage biotechnology, pharmaceutical, and medical device companies, focusing on the healthcare sector in …See details»
Shanghai Zhangke Lingyi Shengfan Venture Capital Center …
Find company research, competitor information, contact details & financial data for Shanghai Zhangke Lingyi Shengfan Venture Capital Center (Limited Partnership) of Shanghai, …See details»
上海张科领弋投资管理有限公司 - 企查查
Aug 26, 2021 2023-11-24 焕擎医疗完成数千万元A轮融资，用于新产品研发与产线建设 2023-08-07 上海生物医药创新转化基金领投上海璃道医药，专注离子通道药物领域创新研发 2023-05-04 …See details»
"Henjing Bio" Secures Over 200 Million Yuan in Series A Financing, …
Oct 29, 2024 Among them, the institutional investor in the Series A round is Shanghai Zhangke Lingyi; the Series A+ round is mainly composed of additional investments from old …See details»
Shanghai Leadingtac Pharmaceutical Secures $13.81 Million in …
Nov 19, 2024 Shanghai Leadingtac Pharmaceutical Co., Ltd., a China-based small molecule drug developer, has announced the successful completion of its Series A financing round, …See details»
上海张科领弋启帆创业投资中心（有限合伙） - 企查查
Apr 5, 2016 Shanghai Zhangke Lingyi Qifan Entrepreneurship Investment Center (Limited Partnership) （自动翻译更新） 主要经营场所 中国（上海）自由贸易试验区张江路665号三层See details»
NewMed Secures $100 Million in Series C Funding - vbdata.cn
Apr 8, 2021 (VCBeat) Mar. 25, 2021 -- Recently, Shanghai-based NewMed Medical Co., Ltd. ("NewMed") announced closing a Series C round of more than $100 million, led by Temasek. …See details»
Shanghai Anti-Tumour R&D Firm Bags USD10 Million in Pre-A …
(Yicai Global) Sept.13 -- Shanghai Ennopharm Co., a start-up focused on the research and development of anti-tumor drugs, has secured USD10 million (CNY65.1 million) in pre-A round …See details»
Zhangke Lingyi Investment - Crunchbase
Zhangke Lingyi Investment is an investment company. Start Free Trial . Chrome ExtensionSee details»
Zhangke Lingyi Investment - Unicorn Nest
Sep 13, 2021 Zhangke Lingyi Investment. Search. Overview Investments Unlock datapoints. Portfolio analytics Team News & Media. Add fund to favorites. Save this fund for later to form …See details»
ImmuneOnco Biopharma imports $25m - globalventuring.com
Oct 15, 2020 Yaluo Investment had supplied an undisclosed amount of pre-series A funding for ImmuneOnco in 2017, the year after an investment from Zhangjiang Technology Investment. …See details»
"New pulse medical" gets more than US $100 million in round C …
Mar 25, 2021 Shanghai newpulse Medical Technology Co., Ltd. announced the completion of more than US $100 million round C financing. In this round of financing, Temasek led …See details»
Lingyi Zhang - Chief Investment Officer - Sumor Korn Partnership
View Lingyi Zhang’s profile on LinkedIn, a professional community of 1 billion members. Private Investment Manager at Sumor Korn · Junior Investment manager, young economist, and …See details»
Leadopharma - Funding, Financials, Valuation & Investors
Aug 7, 2023 Organization. Leadopharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... raised 5 rounds. Their …See details»
Shanghai Maishi Biotechnology Co., Ltd. announced that it has …
On June 7, 2024, Shanghai Maishi Biotechnology Co., Ltd. closed the transaction. The transaction was led by new investor, Shanghai Zhangke Lingyi Qifan Venture Capital Center and included...See details»
Yu Xiaoyong - Crunchbase Person Profile
Nov 18, 2024 Organization Name . Investor Name . Lead Investor . Funding Round . Money Raised . Nov 18, 2024: Lingtai Biotechnology . Zhangke Lingyi Investment ... Zhangke Lingyi …See details»